近期COVID-19疫苗接种后出现症状性淋巴结病和乳腺水肿患者的管理策略
本文讨论近期COVID-19疫苗接种后出现症状性淋巴结病和/或乳腺水肿患者的管理策略。无症状的偶然淋巴结病在筛查乳腺X线摄影中可随访影像或临床管理;有症状且伴乳腺实质异常者需及时诊断评估并考虑组织取样,以避免掩盖恶性肿瘤而延误诊治。
要点
- 无症状的疫苗接种后偶然腋窝淋巴结病,部分专家建议随访影像,另一些建议临床管理而非重复影像或活检。
- 有症状的淋巴结病和/或伴其他异常影像发现者,应按危险因素和临床情况区别处理。
- 疫苗接种后同侧乳腺水肿罕见,水肿可掩盖影像上的潜在异常,有症状且伴乳腺实质异常者需及时诊断评估并考虑组织取样。
核心结论
- 无症状的近期疫苗接种后偶然淋巴结病患者,指南意见不一,部分专家建议随访影像,另一些认为临床管理而非重复影像或活检是合适的。
- 有症状的淋巴结病和/或伴其他异常影像发现者,应根据危险因素和临床情况区别处理。
- 疫苗接种后同侧淋巴结病合并弥漫性乳腺水肿给临床管理带来挑战,因水肿可掩盖影像上的潜在异常。
- 有症状的淋巴结病伴乳腺实质异常者,及时行动是合适的,包括诊断评估并考虑组织取样,可能避免被疫苗症状掩盖的恶性肿瘤延误诊断和治疗。
研究设计与样本
- 本文为针对近期COVID-19疫苗接种后出现症状性淋巴结病和乳腺水肿患者管理策略的论述,原文未报告系统检索范围与纳入文献。
关键影像表现/征象
- 同侧腋窝淋巴结病是与COVID-19疫苗接种相关的有充分记录的表现。
- COVID-19疫苗接种后同侧乳腺水肿罕有报道。
- 同侧淋巴结病合并弥漫性乳腺水肿时,水肿可掩盖影像上的潜在异常。
临床应用与阅片要点
- 无症状的近期疫苗接种后偶然淋巴结病患者,部分专家建议随访影像,另一些专家认为临床管理而非重复影像或活检是合适的。
- 有症状的淋巴结病和/或伴其他异常影像发现者,应根据危险因素和临床情况区别处理。
- 有症状的淋巴结病伴乳腺实质异常者,及时行动是合适的,包括诊断评估并考虑组织取样。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ipsilateral axillary lymphadenopathy is a well-documented finding associated with COVID-19 vaccination. Varying guidelines have been published for the management of asymptomatic patients who have a history of recent vaccination and present with incidental lymphadenopathy at screening mammography. Some experts recommend follow-up imaging, and others suggest that clinical management, rather than repeat imaging or biopsy, is appropriate. Symptomatic patients with lymphadenopathy and/or additional abnormal imaging findings should be treated differently depending on risk factors and clinical scenarios. Although ipsilateral lymphadenopathy is well documented, ipsilateral breast edema after COVID-19 vaccination has been rarely reported. The combination of ipsilateral lymphadenopathy and diffuse breast edema after COVID-19 vaccination presents a clinical management challenge because edema can obscure underlying abnormalities at imaging. For symptomatic patients with lymphadenopathy and associated breast parenchymal abnormality, prompt action is appropriate, including diagnostic evaluation and consideration of tissue sampling. This approach may prevent delays in diagnosis and treatment of patients with malignancy masked by symptoms from the vaccination.
引用
- Hao, Edmonds, Nachiappan, et al. Management Strategies for Patients Presenting With Symptomatic Lymphadenopathy and Breast Edema After Recent COVID-19 Vaccination. AJR Am J Roentgenol. 2021. PMID: 34964358. doi:10.2214/AJR.21.27118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。